Will 60 be the new 40? It might be one day. According to the New Zealand Herald, a new anti-aging drug will be tested on human subjects starting next year. The potential result could mean that we, human beings, could extend our life spans well into our 120s—and be in good health to the very end!
RELATED: 7 diseases you’ll most likely have by age 50 – and how to fend them off
The drug in question is the world’s most widely used diabetes pill called Metformin that costs mere cents to make, and has already been shown to extend the life in roundworms. Metformin helps to increase oxygen flow on the cellular level, thereby slowing the necessary cell divisions that keep our bodies both functioning correctly but ultimately lead to aging.
RELATED: For the aging brain, ways to keep memory sharp
Last year Cardiff University found anecdotal evidence that when patients with diabetes were given the drug metformin they lived longer than others without the condition, even though they should have died eight years earlier on average.
The new clinical trial called Targeting Aging with Metformin, or TAME, is scheduled to begin in the US next winter. Scientists from a range of institutions are currently raising funds and recruiting 3,000 70 to 80-year-olds who have, or are at risk of, cancer, heart disease and dementia.
This could truly be a groundbreaking discovery and we are looking forward to new developments!
RELATED: Age is at least 70% meaningless when it comes to fitness
